Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Alamar Biosciences (Nasdaq: ALMR) will present at the BofA Securities 2026 Healthcare Conference in Las Vegas on Tuesday, May 12, 2026 at 3:40 p.m. PT / 6:40 p.m. ET. A live and archived webcast will be available in the Investors section at investors.alamarbio.com.
Details
News Market Reaction – ALMR
On May 6, the first trading day after this news, ALMR closed 0.25% below the previous close.
Data tracked by StockTitan Argus for the May 6 session.
Key Figures
- Conference year
- 2026
- BofA Securities 2026 Healthcare Conference
- Presentation date
- May 12
- Scheduled conference presentation date
- Presentation time PT
- 3:40 p.m.
- Scheduled presentation time Pacific Time
- Presentation time ET
- 6:40 p.m.
- Scheduled presentation time Eastern Time
Historical Context
-
Initial NASDAQ listing with IPO pricing and commercial traction details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
nasdaq financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
FREMONT, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in Precision Proteomics dedicated to enabling the earliest detection of disease, today announced it will be participating in the upcoming BofA Securities 2026 Healthcare Conference in Las Vegas, Nevada.
Alamar Biosciences’ management is scheduled to present on Tuesday, May 12, at 3:40 p.m. Pacific Time / 6:40 p.m. Eastern Time. Interested parties may access a live and archived webcast of the session on the “Investors” section of the company website at investors.alamarbio.com.
About Alamar Biosciences, Inc.
Alamar is a life sciences company dedicated to powering Precision Proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar’s platform is designed to detect biomarkers with ultra-high sensitivity and address key limitations of existing technologies, helping researchers unlock the full spectrum of protein biomarkers across disease states.
Investor contact:
Media contact:
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.